Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PRP Intra-ovarian Infusion in POI Patients
NCT04031456Phase 3Recruiting
- Sponsor
- Genesis Athens Clinic
- Start
- Jul 2019
- Primary completion
- Jan 2027
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 3 trial of autologous platelet-rich plasma in primary ovarian insufficiency (POI), sponsored by Genesis Athens Clinic. Started Jul 2019; status: recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT04031456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04031456.